Can gabapentin (Neurontin) cause blurry vision?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Gabapentin Cause Blurry Vision?

Yes, gabapentin commonly causes blurred vision as a recognized adverse effect, occurring in approximately 3-4% of patients in clinical trials, with the FDA label specifically listing "amblyopia" (reported as blurred vision) as a documented side effect. 1

Evidence from FDA Drug Label and Guidelines

The FDA-approved drug label for gabapentin explicitly documents blurred vision as an adverse reaction:

  • In postherpetic neuralgia trials: Amblyopia (reported as blurred vision) occurred in 3% of gabapentin-treated patients versus 1% of placebo patients 1
  • In epilepsy trials: Amblyopia (often described as blurred vision) occurred in 4% of gabapentin-treated patients versus 1% of placebo patients 1
  • The incidence is dose-related and more common at higher doses 1

Comparison with Related Medications

Pregabalin, a closely related medication to gabapentin, causes blurred vision at even higher rates:

  • Pregabalin is associated with large increases in blurred vision (evidence type 2) 2
  • In breast surgery trials, pregabalin increased the incidence of blurred vision, though gabapentin did not show this effect in the specific studies reviewed 2
  • Both medications share similar adverse effect profiles, with pregabalin generally causing more pronounced visual disturbances 3

Clinical Context and Mechanism

The visual disturbances from gabapentin are primarily neurotoxic effects rather than structural eye damage:

  • Gabapentin causes non-specific neurotoxic visual abnormalities including diplopia, blurred vision, and nystagmus 4
  • These effects are often transient and related to the drug's CNS effects rather than direct ocular toxicity 5
  • Visual problems typically emerge early in treatment but may resolve by week 4 as tolerance develops 6

Real-World Impact

The visual side effects have practical safety implications:

  • Blurred vision, drowsiness, and loss of coordination are reported side effects that impair driving ability 7
  • In drugged driving investigations, 94% of gabapentin cases involved crashes where drivers exhibited behaviors consistent with visual and coordination impairment 7
  • Half of the reviewed driving cases involving gabapentin resulted in crashes where the driver was at fault 7

Clinical Management Recommendations

When prescribing gabapentin, counsel patients specifically about visual side effects:

  • Start with lower doses (100-300 mg at bedtime) and titrate slowly to minimize side effects 8
  • Warn patients about blurred vision and advise against driving until they know how the medication affects them 1, 7
  • Monitor for visual complaints during the first few weeks, as early side effects often resolve with continued use 6
  • Consider dose reduction if blurred vision becomes problematic, as the effect is dose-dependent 1

Important Caveats

  • Unlike some antiepileptics (such as vigabatrin), gabapentin does not cause permanent structural damage to the retina or visual field defects 4
  • The blurred vision is generally reversible upon dose reduction or discontinuation 5
  • Never abruptly discontinue gabapentin; taper gradually to avoid withdrawal symptoms including potential seizures 6, 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pregabalin: new drug. Very similar to gabapentin.

Prescrire international, 2005

Guideline

Onset of Action of Gabapentin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Gabapentin in drugged driving investigations.

Journal of forensic sciences, 2024

Guideline

Gabapentin Dosage and Administration for Neuropathic Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.